期刊文献+

糖尿病腹膜透析患者的胰岛素应用 被引量:1

下载PDF
导出
摘要 糖尿病肾病是糖尿病最常见的微血管并发症之一,随着糖尿病患病率的不断上升,糖尿病肾病已成为终末期肾病(ESRD)的首位病因,约占30%~40%,所导致的肾脏替代治疗也逐年增加。肾脏替代方法包括血液透析(haemodialysis,HD)、腹膜透析(peritoneal dialysis,PD)和肾脏移植。
出处 《药品评价》 CAS 2010年第1期25-28,共4页 Drug Evaluation
  • 相关文献

参考文献19

  • 1Amair P;Khanna R;Leibel B.查看详情[J]New England Journal of Medicine,1982.
  • 2Quellhorst E.查看详情[J]Journal of the American Society of Nephrology,2002(01).
  • 3Dasgupta MK.查看详情[J]Advances in Peritoneal Dialysis,2004.
  • 4Noah D.Lubowsky;Siegel R.查看详情[J]American Journal of Kidney Diseases,2007(05).
  • 5Yu CC;Wu MS;Wu CH.查看详情[J]Peritoneal Dialysis International,1997(03).
  • 6Ponikvar R;Buturovic Ponikvar J.查看详情[J]Nephrology Dialysis Transplantation,2001(06).
  • 7Lino S;Sergio B;Roberto S.查看详情[J]Peritoneal Dialysis International,1996(01).
  • 8Wong TY;Szeto CC;Chow KM.Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.[J],2005(04).
  • 9叶映玲,刘红勇,陈小娟.糖尿病肾病行CAPD时胰岛素腹腔内给药的应用和护理[J].吉林医学,2007,28(18):1929-1930. 被引量:1
  • 10Marshall J;Jennings P;ScottA.查看详情[J]Kidney International,2003.

二级参考文献16

  • 1[1]Lino S, Sergio B, Roberto S, et al. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intrapetitoneal versus subcutaneous treatment. Petit Dial Int, 1996, 16 (suppl 1): S275- 278
  • 2[2]Ponikvar R, Buturovic Ponikvar J. Management of diabetic patients with hecmedialysis, peritoneal dialysis, and renal transplantation. Nephrol Dial Transplant, 2001, 16 (suppl 6) :94 - 96
  • 3[3]Yu CC, Wu MS, Wu CH,et al. Predialysis glycemic control is an independent predictor of clinical outcome in type Ⅱ diabetics on continuous ambulatory peritoneal dialysis. Petit Dial Int, 1997, 17(3) :262 - 268
  • 4[4]Ednard Q. Advisability of switching of IP insulin in to CAPD. Seminars in dialysis, 2002, 15(5) :376
  • 5[5]Anseri A, MB, BS, et al. Assessing glycemic control in patients with diabetes and end- stage renal failure. Am J Kidney Dis, 2003, 14(3):523 - 531
  • 6[6]Misrs M. and Nolph K (2000). Peritoneal dialysis in diabetic endstage renal disease. In: Gokal R. Khanna R. Krediet R and Nolph K (eds). Textbook of peritoneal dilaysis. Dordrecht, Kluwer Academic Publishers, 2000, 647 - 666
  • 7[7]Wang T, Heimburger O, Waniewski J, et al. Increased peritoneal permeability is associated with decreased fluid and small solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant, 1998, 13:1242- 1249
  • 8叶任高.临床肾脏病学[M].北京:人民卫生出版社,1999.80-82.
  • 9Barre D E,Adv Perit Dial,1999年,15卷,12页
  • 10Chen C J,Adv Perit Dial,1998年,14卷,116页

共引文献14

同被引文献5

  • 1Szeto CC, Chow KM, Leung CB, et al. Increased subcutaneous insulin requirements in diabetic patients recently commenced onperitoneal dialysis [ J ]. Nephrol Dial Transplant, 2007, 22 (6) : 1697-1702.
  • 2Hamburger RJ. How can the poor outcomes for diabetic dialysis patients be improved [ J ]. Semin Dial, 2004, 17 (3) : 190-191.
  • 3Babazono T, Nakamoto H, Kasai K, et al. Effects of icodextrin on lhycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis[J]. Am J Nephrol, 2007, 27(4): 409-415.
  • 4张亚红,姬漫,张少华.小剂量胰岛素治疗糖尿病酮症酸中毒48例[J].临床医学,2008,28(12):40-41. 被引量:2
  • 5陈孟华,甘红兵,董捷,汪涛.糖尿病腹膜透析患者胰岛素治疗方案探讨[J].中国血液净化,2004,3(5):243-246. 被引量:9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部